Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Applications' CEO Dispels Rumors of Sale

Premium

PALO ALTO, Calif.--Dispelling industry rumors that Molecular Applications Group is up for sale, Debbie Yu, acting CEO, said the company is seeking partnerships, but not a buyer. "MAG is definitely not on the block, but we are pursuing conversations with a number of strategic players because it is a cornerstone of our business plan to do that," Yu said. Rumors about the company's financial health heated up recently after John Andrews, executive vice-president and chief operating officer, departed from the company.

"I hear the same rumors," Yu said, "but we have not hired a bank to sell the company, we have not made any strategic efforts to sell, we have a CEO search under way, and we are planning to do another round of financing to raise $5-$10 million in the next few months. These are things you do when you're keeping a company going."

Still, Yu acknowledged, "You can never say never. Most companies in our space will either die or merge. Very few bioinformatics companies are ever going to go public."

Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.